94
To medicines for novel therapies (Advanced Therapy Medicinal Products, ATMP) zählen drug with recombinant nucleic acids such as CAR-T cell therapeutics, somatic cell therapies and tissue engineered products. 18 ATMPs currently have EU approval. An excerpt from it was illuminated by Professor Dr. Thomas KlingebielManaging Director of Help for Cancer Patients Kinder Frankfurt am Mainin his lecture »drug for novel therapies: Perspectives, Opportunities, Challenges” at the advanced training congress Pharmacon in Merano.